Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?

Plus

16

Ṁ1142

resolved Jan 7

Resolved

YES

1D

1W

1M

ALL

The rise of GPL-1 agonists as "miracle" drugs to cure obesity, hypertension, and a myriad of social issues related to an unhealthy body mass has been nothing short of stunning -- as important as the development of AI. But we are just learning about the other potential effects of these. Will a new clinical trial at least confirm what we think we know about this class of drugs?

This question is managed and resolved by Manifold.

#Weight loss drugs

Get

1,000

and

3.00

🏅 Top traders

#	Name	Total profit
1		Ṁ32
2		Ṁ26
3		Ṁ17
4		Ṁ14
5		Ṁ14

Sort by:

I'm double-checking medical journals this week. It's not as straightforward as you might think. One of the two studies linked below was not published in 2024 but in 2023. Have a bit more patience, please. (Not inactive, Paper, just traveling.)

@MikeLewis sorry! I get impatient too often (a bad habit). Thank you!

@MikeLewis how will this resolve?

[deleted]

https://link.springer.com/article/10.1007/s00125-023-06053-9

https://www.sciencedirect.com/science/article/pii/S0168827824023626

sold Ṁ85 NO

@JaimeSantaCruz yeah I think this is good enough evidence for yes

Related questions

Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?

Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?

Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027

Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss

Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?

Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?

[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...

What fraction of US adults will regularly take GLP-1 drugs in 2030?

Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?

Before 2033, will semaglutide be shown to improve lifespan, when prescribed to overweight people?

Related questions

Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?

Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?

Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?

[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...

Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027

What fraction of US adults will regularly take GLP-1 drugs in 2030?

Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss

Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?

Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?

Before 2033, will semaglutide be shown to improve lifespan, when prescribed to overweight people?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules